Need to channel Maggie Smith’s ‘Good Bones’ talking to the kids this morning….
“The world is at least fifty percent terrible, and that’s a conservative estimate, though I keep this from my children”
The affective gradient hypothesis: an affect-centered account of motivated behavior
Opinion by Amitai Shenhav (@amitaishenhav)
Free access before Nov 13: https://t.co/ADW90jSxkl
What kind of childhood makes a top scientist? Is it enough to have all the right traits (brilliance, grit, etc) or do you need the right family too?
And why should we care? A 🧵 on our paper on the Nobel Laureates.
A teaser: the income distribution of the laureates' fathers.1/N
Really stimulating time at #epbs2024 thanks @MayoOnTheBrain for the invite and all the other organisers for a great programme. The view was not bad either…
It will always be moving no matter how many times we lay these 4305 flowers for people who died from drugs in the UK in one year. And chilling, because all their deaths were avoidable if only we did things differently
We're at @anyoneschild Waterlooville "Let's Talk Drugs" event
Our second symposium of the day focused on Ketamine and its impact on mental health and substance use disorders. We had talks from @ArgelAV@ZoeAHughes11 & @profceliamorgan. #EBPS2024 (my phone does not like this projector, apologies for the yellowness)
Finally, we will hear from Dr Alex Shaw from @UniofExeter who will be discussing
"Ketamine-enhanced inhibitory connectivity and dissociative symptoms in individuals at risk for gambling disorder"
#BAP2024 🧵 THREAD
@eturnermd1 #MDMAadcomm VOTE 2/2: Do the benefits of midomafetamine with FDA’s proposed risk evaluation and mitigation strategy (REMS) outweigh its risks for the treatment of patients with PTSD?
1-Yes
10-No
0-Abstain
After careful consideration, the FDA advisory comission voted today 9:2 that MDMA has *not* been shown to be effective for treating PTSD, given massive concerns around validity threats in this literature. They also voted 10:1 that MDMA has *not* shown to be safe.
Please RT: We’re running a study looking at people’s experience of ketamine addiction treatment - heavy ketamine users current and past welcome https://t.co/HxkO2szcft
Please RT: We’re running a study looking at people’s experience of ketamine addiction treatment - heavy ketamine users current and past welcome https://t.co/HxkO2szcft
Systematic review of 10 #esketamine RCTs for #depression finds that ~40% of adverse events are omitted from publications—nearly all of those events (94%) happened to participants in the esketamine (not placebo) arm.
Overall reporting quality 'poor'.
https://t.co/iLWxbYY9Wr